Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Research Abstract |
Using human melanoma cells, we demonstrated that diacylglycerol kinase (DGK) alpha enhanced tumor necrosis factor-alpha (TNF-alpha)-induced activation of nuclear factor-kappaB (NF-kappaB) via protein kinase Czeta-dependent phosphorylation of a large subunit of NF-kappaB, p65/RelA. We found that the both of DGKalpha-specfic siRNA and TNF-alpha significantly attenuated the melanoma tumor growth in mice. DGKalpha is suggested to be a novel therapeutic target for melanoma.
|